We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...
Zacks.com on MSN4d
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You TradeCRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.
In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...
CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...
Zacks.com on MSN1d
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?The fall in CRSP stock can be attributed to a lack of pipeline updates. Despite securing approval for its first marketed product in early 2024, CRSP is yet to record product sales.
EST Cathie Wood’s ARK Investment bought 133K shares of Crispr Therapeutics (CRSP) todayStay Ahead of the Market:Discover outperforming ...
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
NEW YORK & CHICAGO–(BUSINESS WIRE)–OptionMetrics, an options database and analytics provider for institutional investors and academic researchers worldwide, and CRSP, Center for Research in Security ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback